Cargando…

Neuropsychological function at first episode in treatment-resistant psychosis: findings from the ÆSOP-10 study

BACKGROUND: Neuropsychological investigations can help untangle the aetiological and phenomenological heterogeneity of schizophrenia but have scarcely been employed in the context of treatment-resistant (TR) schizophrenia. No population-based study has examined neuropsychological function in the fir...

Descripción completa

Detalles Bibliográficos
Autores principales: Kravariti, Eugenia, Demjaha, Arsime, Zanelli, Jolanta, Ibrahim, Fowzia, Wise, Catherine, MacCabe, James H., Reichenberg, Abraham, Pilecka, Izabela, Morgan, Kevin, Fearon, Paul, Morgan, Craig, Doody, Gillian A., Donoghue, Kim, Jones, Peter B., Kaçar, Anil Şafak, Dazzan, Paola, Lappin, Julia, Murray, Robin M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6712950/
https://www.ncbi.nlm.nih.gov/pubmed/30348234
http://dx.doi.org/10.1017/S0033291718002957
_version_ 1783446786786983936
author Kravariti, Eugenia
Demjaha, Arsime
Zanelli, Jolanta
Ibrahim, Fowzia
Wise, Catherine
MacCabe, James H.
Reichenberg, Abraham
Pilecka, Izabela
Morgan, Kevin
Fearon, Paul
Morgan, Craig
Doody, Gillian A.
Donoghue, Kim
Jones, Peter B.
Kaçar, Anil Şafak
Dazzan, Paola
Lappin, Julia
Murray, Robin M.
author_facet Kravariti, Eugenia
Demjaha, Arsime
Zanelli, Jolanta
Ibrahim, Fowzia
Wise, Catherine
MacCabe, James H.
Reichenberg, Abraham
Pilecka, Izabela
Morgan, Kevin
Fearon, Paul
Morgan, Craig
Doody, Gillian A.
Donoghue, Kim
Jones, Peter B.
Kaçar, Anil Şafak
Dazzan, Paola
Lappin, Julia
Murray, Robin M.
author_sort Kravariti, Eugenia
collection PubMed
description BACKGROUND: Neuropsychological investigations can help untangle the aetiological and phenomenological heterogeneity of schizophrenia but have scarcely been employed in the context of treatment-resistant (TR) schizophrenia. No population-based study has examined neuropsychological function in the first-episode of TR psychosis. METHODS: We report baseline neuropsychological findings from a longitudinal, population-based study of first-episode psychosis, which followed up cases from index admission to 10 years. At the 10-year follow up patients were classified as treatment responsive or TR after reconstructing their entire case histories. Of 145 cases with neuropsychological data at baseline, 113 were classified as treatment responsive, and 32 as TR at the 10-year follow-up. RESULTS: Compared with 257 community controls, both case groups showed baseline deficits in three composite neuropsychological scores, derived from principal component analysis: verbal intelligence and fluency, visuospatial ability and executive function, and verbal memory and learning (p values⩽0.001). Compared with treatment responders, TR cases showed deficits in verbal intelligence and fluency, both in the extended psychosis sample (t = −2.32; p = 0.022) and in the schizophrenia diagnostic subgroup (t = −2.49; p = 0.017). Similar relative deficits in the TR cases emerged in sub-/sensitivity analyses excluding patients with delayed-onset treatment resistance (p values<0.01–0.001) and those born outside the UK (p values<0.05). CONCLUSIONS: Verbal intelligence and fluency are impaired in patients with TR psychosis compared with those who respond to treatment. This differential is already detectable – at a group level – at the first illness episode, supporting the conceptualisation of TR psychosis as a severe, pathogenically distinct variant, embedded in aberrant neurodevelopmental processes.
format Online
Article
Text
id pubmed-6712950
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-67129502019-09-05 Neuropsychological function at first episode in treatment-resistant psychosis: findings from the ÆSOP-10 study Kravariti, Eugenia Demjaha, Arsime Zanelli, Jolanta Ibrahim, Fowzia Wise, Catherine MacCabe, James H. Reichenberg, Abraham Pilecka, Izabela Morgan, Kevin Fearon, Paul Morgan, Craig Doody, Gillian A. Donoghue, Kim Jones, Peter B. Kaçar, Anil Şafak Dazzan, Paola Lappin, Julia Murray, Robin M. Psychol Med Original Articles BACKGROUND: Neuropsychological investigations can help untangle the aetiological and phenomenological heterogeneity of schizophrenia but have scarcely been employed in the context of treatment-resistant (TR) schizophrenia. No population-based study has examined neuropsychological function in the first-episode of TR psychosis. METHODS: We report baseline neuropsychological findings from a longitudinal, population-based study of first-episode psychosis, which followed up cases from index admission to 10 years. At the 10-year follow up patients were classified as treatment responsive or TR after reconstructing their entire case histories. Of 145 cases with neuropsychological data at baseline, 113 were classified as treatment responsive, and 32 as TR at the 10-year follow-up. RESULTS: Compared with 257 community controls, both case groups showed baseline deficits in three composite neuropsychological scores, derived from principal component analysis: verbal intelligence and fluency, visuospatial ability and executive function, and verbal memory and learning (p values⩽0.001). Compared with treatment responders, TR cases showed deficits in verbal intelligence and fluency, both in the extended psychosis sample (t = −2.32; p = 0.022) and in the schizophrenia diagnostic subgroup (t = −2.49; p = 0.017). Similar relative deficits in the TR cases emerged in sub-/sensitivity analyses excluding patients with delayed-onset treatment resistance (p values<0.01–0.001) and those born outside the UK (p values<0.05). CONCLUSIONS: Verbal intelligence and fluency are impaired in patients with TR psychosis compared with those who respond to treatment. This differential is already detectable – at a group level – at the first illness episode, supporting the conceptualisation of TR psychosis as a severe, pathogenically distinct variant, embedded in aberrant neurodevelopmental processes. Cambridge University Press 2019-09 2018-10-23 /pmc/articles/PMC6712950/ /pubmed/30348234 http://dx.doi.org/10.1017/S0033291718002957 Text en © Cambridge University Press 2018 http://creativecommons.org/licenses/by/4.0/ This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Kravariti, Eugenia
Demjaha, Arsime
Zanelli, Jolanta
Ibrahim, Fowzia
Wise, Catherine
MacCabe, James H.
Reichenberg, Abraham
Pilecka, Izabela
Morgan, Kevin
Fearon, Paul
Morgan, Craig
Doody, Gillian A.
Donoghue, Kim
Jones, Peter B.
Kaçar, Anil Şafak
Dazzan, Paola
Lappin, Julia
Murray, Robin M.
Neuropsychological function at first episode in treatment-resistant psychosis: findings from the ÆSOP-10 study
title Neuropsychological function at first episode in treatment-resistant psychosis: findings from the ÆSOP-10 study
title_full Neuropsychological function at first episode in treatment-resistant psychosis: findings from the ÆSOP-10 study
title_fullStr Neuropsychological function at first episode in treatment-resistant psychosis: findings from the ÆSOP-10 study
title_full_unstemmed Neuropsychological function at first episode in treatment-resistant psychosis: findings from the ÆSOP-10 study
title_short Neuropsychological function at first episode in treatment-resistant psychosis: findings from the ÆSOP-10 study
title_sort neuropsychological function at first episode in treatment-resistant psychosis: findings from the æsop-10 study
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6712950/
https://www.ncbi.nlm.nih.gov/pubmed/30348234
http://dx.doi.org/10.1017/S0033291718002957
work_keys_str_mv AT kravaritieugenia neuropsychologicalfunctionatfirstepisodeintreatmentresistantpsychosisfindingsfromtheæsop10study
AT demjahaarsime neuropsychologicalfunctionatfirstepisodeintreatmentresistantpsychosisfindingsfromtheæsop10study
AT zanellijolanta neuropsychologicalfunctionatfirstepisodeintreatmentresistantpsychosisfindingsfromtheæsop10study
AT ibrahimfowzia neuropsychologicalfunctionatfirstepisodeintreatmentresistantpsychosisfindingsfromtheæsop10study
AT wisecatherine neuropsychologicalfunctionatfirstepisodeintreatmentresistantpsychosisfindingsfromtheæsop10study
AT maccabejamesh neuropsychologicalfunctionatfirstepisodeintreatmentresistantpsychosisfindingsfromtheæsop10study
AT reichenbergabraham neuropsychologicalfunctionatfirstepisodeintreatmentresistantpsychosisfindingsfromtheæsop10study
AT pileckaizabela neuropsychologicalfunctionatfirstepisodeintreatmentresistantpsychosisfindingsfromtheæsop10study
AT morgankevin neuropsychologicalfunctionatfirstepisodeintreatmentresistantpsychosisfindingsfromtheæsop10study
AT fearonpaul neuropsychologicalfunctionatfirstepisodeintreatmentresistantpsychosisfindingsfromtheæsop10study
AT morgancraig neuropsychologicalfunctionatfirstepisodeintreatmentresistantpsychosisfindingsfromtheæsop10study
AT doodygilliana neuropsychologicalfunctionatfirstepisodeintreatmentresistantpsychosisfindingsfromtheæsop10study
AT donoghuekim neuropsychologicalfunctionatfirstepisodeintreatmentresistantpsychosisfindingsfromtheæsop10study
AT jonespeterb neuropsychologicalfunctionatfirstepisodeintreatmentresistantpsychosisfindingsfromtheæsop10study
AT kacaranilsafak neuropsychologicalfunctionatfirstepisodeintreatmentresistantpsychosisfindingsfromtheæsop10study
AT dazzanpaola neuropsychologicalfunctionatfirstepisodeintreatmentresistantpsychosisfindingsfromtheæsop10study
AT lappinjulia neuropsychologicalfunctionatfirstepisodeintreatmentresistantpsychosisfindingsfromtheæsop10study
AT murrayrobinm neuropsychologicalfunctionatfirstepisodeintreatmentresistantpsychosisfindingsfromtheæsop10study